Avid Bioservices Inc (CDMO)

[Protector]

sulco, maybe you should have provided the link and the rest of the story.

PPHM had idle capacity since Avid II was up and running. So what? There forecast was (for now): SAME AS PAST FISCAL YEAR.

And you omitted the 3 customers that got FDA approved and 2 new ones. SO you site IDLE capacity and forget about the opportunities. Did you tell that to the maître d'?

Furthermore PPHM have themselves on August 11th 2017 said they are again, after removing 60% of R&D people, positioning for overall profitability:

and better position the Company to achieve overall profitability

And if they realise the 4.5Mil$ cut and we look at last FY then they are pretty close to break-even. So orders for about 500K$ from those newly approved customers may make the difference.

So yes, RONIN fear talk, no REAL TALK.

AIMO